News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
101 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33091)
2026 (17234)
Month
January (2936)
February (2968)
March (2710)
April (2908)
May (3626)
June (2409)
July (2088)
August (2590)
September (2381)
October (3064)
November (3189)
December (2222)
Day
2 (13)
3 (111)
4 (147)
5 (162)
6 (150)
7 (96)
9 (24)
10 (101)
11 (117)
12 (135)
13 (125)
14 (151)
17 (94)
18 (131)
19 (207)
20 (168)
21 (96)
24 (160)
25 (182)
26 (291)
27 (213)
28 (94)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
9
10
11
12
13
14
17
18
19
20
21
24
25
26
27
28
Press Releases
IMUNON Appoints Douglas V. Faller, M.D., Ph.D., as Chief Medical Officer
February 10, 2025
·
8 min read
Press Releases
Palvella Therapeutics to Expand Phase 3 SELVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Microcystic Lymphatic Malformations to Include the Younger Pediatric Population, Children 3 to 5 Years Old
February 10, 2025
·
7 min read
Press Releases
Scholar Rock to Host Conference Call to Discuss Fourth Quarter and Full-Year 2024 Financial Results and Provide Business Update on February 27, 2025
February 10, 2025
·
2 min read
Press Releases
OliX and Lilly Enter Global Licensing Agreement for MASH and Other Cardiometabolic Indications
February 10, 2025
·
2 min read
Press Releases
Oncocyte Prices $29.1 Million Equity Offering
February 10, 2025
·
7 min read
Press Releases
Medera’s Novoheart Expands Human Cardiac Research with CTScreen™ Installation at University Medical Center, Utrecht
February 10, 2025
·
14 min read
Press Releases
Recludix Pharma to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 10, 2025
·
1 min read
Press Releases
Norlase Appoints Jacob Philipsen as Chairman of the Board of Directors
February 10, 2025
·
2 min read
Press Releases
Bio-Thera Solutions Announces Exclusive Commercialization and License Agreement with Intas Pharmaceuticals for BAT2506, a Proposed Biosimilar Referencing Simponi® (golimumab), in the United States of America
February 10, 2025
·
6 min read
Press Releases
Immune Response Data for INO-3107 to be Presented as a Poster at American Association for Cancer Research Immuno-Oncology (AACR-IO) Conference
February 10, 2025
·
1 min read
Previous
9 of 11
Next
